Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.48 USD | -6.05% |
|
+4.88% | +211.88% |
07-09 | JPMorgan Adjusts Price Target on Dyne Therapeutics to $43 From $39, Maintains Overweight Rating | MT |
07-01 | Dyne Therapeutics, Inc.(NasdaqGS:DYN) dropped from Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+211.88% | 4.38B | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- DYN Stock
- News Dyne Therapeutics, Inc.
- JPMorgan Adjusts Price Target on Dyne Therapeutics to $43 From $39, Maintains Overweight Rating